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INTRODUCTION 
 
Telomeres are highly conserved repetitive DNA 
sequences that cap chromosomes [1] and are important 
in maintaining genetic stability by protecting against 
genetic recombination, end-to-end fusion of the 
chromosome and cellular degradation [2, 3]. Somatic 
cell telomeres shorten with each round of mitotic 
division  until  they  become too short to divide resulting  
 
in cellular senescence [4]. In somatic tissues, telomere 
length (TL) is established early in life [5, 6], and 
shortens with older age [7, 8]. Skeletal muscle is a 
minimally proliferative tissue compared with leukocytes, 
and therefore, TL in skeletal muscle is in general longer 
than in leukocytes [6]. The length of telomeres varies 
considerably between individuals of the same 
chronological age and is therefore indicative of 
biological age [8]. The inter-individual variability in TL 
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ABSTRACT 
 
A reduction in aerobic capacity and the shortening of telomeres are hallmarks of the ageing process. We 
examined whether a lower aerobic capacity is associated with shorter TL in skeletal muscle and/or leukocytes, 
across a wide age range of individuals. We also tested whether TL in human skeletal muscle (MTL) correlates 
with TL in leukocytes (LTL). Eighty-two recreationally active, healthy men from the Gene SMART cohort 
(31.4±8.2 years; body mass index (BMI)=25.3±3.3kg/m2), and 11 community dwelling older men (74.2±7.5years-
old; BMI=28.7±2.8kg/m2) participated in the study. Leukocytes and skeletal muscle samples were collected at 
rest. Relative telomere length (T/S ratio) was measured by RT-PCR. Associations between TL, aerobic capacity 
(VO2 peak and peak power) and age were assessed with robust linear models. Older age was associated with 
shorter LTL (45% variance explained, P<0.001), but not MTL (P= 0.7). Aerobic capacity was not associated with 
MTL (P=0.5), nor LTL (P=0.3). MTL and LTL were correlated across the lifespan (rs=0.26, P=0.03). In healthy 
individuals, age explain most of the variability of LTL and this appears to be independent of individual aerobic 
capacity. Individuals with longer LTL also have a longer MTL, suggesting that there might be a shared molecular 
mechanism regulating telomere length. 
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is thought to be influenced by genetics, epigenetics and 
environ-mental factors including oxidative stress, and 
inflammation [9–12]. 
 
TL is associated with some, but not all, ageing and 
disease-related traits [13, 14]. Literature is inconsistent 
regarding TL and all-cause mortality with some [7, 15] 
but not all studies [16, 17] finding that a shorter TL is 
associated with increased risk of all-cause mortality. 
Some studies show that a shorter TL is associated with 
age-related conditions such as cardiovascular disease 
[18, 19] and diabetes mellitus [9, 20]. While in cancer 
the literature is conflicted regarding risk of cancer and 
TL [7, 21–23] with suggestions that perhaps a “U-
shaped” risk association may exist between very short 
and very long telomeres and risk of different types 
cancer [12, 22, 24, 25]. In two recent papers, there was 
no association between TL and cognitive function, grip 
strength, frailty and sarcopenia [13, 26]; suggesting that 
telomere length may not be a marker of all ageing and 
disease-related traits. 
 
It is well established that regular physical activity 
promotes healthy ageing and reduces the risk of 
developing these chronic diseases [27, 28]. Engagement 
in exercise is associated with longer telomeres  
and may slow down TL shortening [29]. Higher 
aerobic capacity is associated with longer leukocyte 
TL in endurance trained athletes [30–32] and young 
(18–32 yrs) [33] and older exercised-trained adults 
(55–72yrs) when compared to controls [34]. However, 
the literature regarding TL in skeletal muscle is 
conflicting, with only few studies reporting a positive 
association between higher levels of physical activity 
and longer telomeres in young and older healthy 
populations [35–37]; while other studies reported no 
association between skeletal muscle TL and exercise 
training levels [38, 39]. The variability in findings was 
highlighted in a systematic review where 54% of 
studies found no association between physical activity 
and skeletal muscle TL [40]. Physical activity  
was assessed using a multitude of subjective measures  
of physical activity (questionnaires) or motion  
sensors (accelerometers), which could account for the 
conflicting results. 
 
To make use of TL as biomarker of ageing and in 
predicting health outcomes, more research is required to 
understand the inter-individual variation in TL and its 
attrition across the human lifespan. Therefore, the aim of 
this study was to examine whether aerobic capacity 
(defined using gold-standard measures) is associated 
with TL in skeletal muscle and/or leukocytes, across a 
wide age range (18–87 years). We also investigated 
whether TL in human skeletal muscle is associated with 
TL in leukocytes. 
RESULTS 
 
The young cohort had a lower BMI, were fitter (higher 
V̇O2peak and peak power), and harboured longer LTL 
than the older cohort. However, there was no difference 
in MTL between the young and old cohort (Table 1). 
 
Fitness parameters and telomere length 
 
After adjustment for age, none of the fitness parameters 
(Supplementary Table 1) or the combined aerobic 
capacity score were associated with LTL (β= 0.06, P= 
0.3; 95% CI= -0.1, 0.2) or MTL (β= 0.08, P= 0.5; 95% 
CI= -0.1, 0.2) (Figure 1). 
 
Overall, age was associated with a shorter LTL (β= -
0.45, P<0.001; 95% CI= -0.029, -0.013) but not with 
MTL (β = -0.06, P=0.73, 95% CI= -0.009, 0.005) 
(Figure 2). Longer MTL was associated with longer 
LTL (rs=0.22, p=0.046) across the lifespan (Figure 3). 
 
DISCUSSION 
 
In this study, we confirmed that TL shortens with age in 
leukocytes of apparently healthy men, and that LTL and 
MTL are correlated. However, TL was not associated 
with age in skeletal muscle, and aerobic capacity was not 
associated with longer telomeres in either leukocytes or 
skeletal muscle. In addition, a significant correlation was 
found between LTL and MTL indicating that individuals 
with a short (or long) telomeres in one tissue also display 
a short (or long) telomeres in another tissue, consistent 
with previous reports [6]. Overall, age explains most of 
the variability of LTL and this appears to be independent 
of individual aerobic capacity. While MTL appears to be 
stable (regardless of age and level of fitness) across the 
lifespan. Further, since it is correlated with LTL, MTL 
could serve as a reference to indicate shortening in LTL 
since early-life. 
 
TL in somatic tissues is established early in life [5, 6] 
and linearly decreases with age after the age of 20 years 
[7, 8]. The association between TL and age in 
leukocytes, but not in skeletal muscle, indicates that the 
TL shortening is variable across different tissues. This is 
most likely due to the different proliferative capacity and 
the number cell divisions that take place across the 
human life-span in each tissue [41, 42]. An inverse 
correlation between age and LTL was found in our 
cohort with age accounting for 45% of the variation in 
TL, which is consistent with literature [8]. It is well 
known that leukocytes are a highly proliferative tissue 
and undergo rapid cell division at two different stages of 
life, during the first years of life and in older age 
(~60yrs), and hence a strong correlation with age is 
observed [42, 43]. There is limited data on the  
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association between age and MTL in healthy 
populations, with most studies having examined the 
correlation in populations who live with chronic 
diseases, thus making it difficult to delineate the effect 
of age and disease status on telomere length [42, 44]. 
Due to the minimal proliferative capacity of skeletal 
muscle, it is thought that MTL is maintained throughout  
 
adult life and only shortens in response to trauma or 
disease [45, 46]. Our data also imply a tissue-specific 
molecular mechanism in skeletal muscle that is 
maintaining telomere length [45, 47]. In line with this, 
these data show that age is not associated with MTL in a 
apparently healthy population, consistent with some  
[48, 49], but not all reports [6]. 
 
We report that a higher LTL is associated with a higher 
MTL. While LTL undergoes a faster rate of attrition 
with age than MTL, the inter-individual difference in TL 
is much larger than the intra-individual difference in TL 
across tissues [5, 6]. Therefore, an individual with short 
(or long) telomeres in leukocytes will display 
corresponding short (or long) telomeres in skeletal 
muscle. This finding extends knowledge from previous 
studies which have reported a correlation in foetuses and 
children [5] and in adults aged between 19–77 years [6]. 
Overall, these results suggest that the impact of age on 
telomere attrition is more apparent in highly proliferative 
tissue than in minimally proliferative tissue. 
 
While the benefits of physical activity on ageing and 
age-related conditions are well known [27, 28], the 
benefits on cellular regeneration and senescence are less 
clear. Our data are in line with a growing body of 
literature indicating that higher aerobic capacity is not 
associated with telomere length after adjusting for age 
[40, 50]. Specifically, we showed that age is the major 
contributing factor to variability in LTL. We hypo-
thesise that the lack of association may be specific to 
the population used in this study, i.e. apparently healthy 
men, with relatively high levels of fitness, according to 
a recent paper reporting quantile reference values for 
peak oxygen uptake (V̇O2peak) [51]. It is possible that 
TL is maintained at this level of fitness [34, 52]. The 
literature around TL and self-reported physical activity 
supports this with those with high levels of habitual 
physical activity having longer LTL, compared with 
individuals with low and moderate habitual physical 
activity [53]. Therefore, perhaps the lack of association 
of aerobic capacity with TL may due to the high level of 
fitness exhibited in this cohort and the lack of 
representation of individuals with a low level of fitness. 
Table 1. Participant characteristics. 
Characteristics Young n=82 Older n=11 P value 
Age (Years) 31.4 ± 8.3 74.2 ± 7.5 P<0.001 
BMI (kg.m-2) 25.2 ± 3.3 28.7 ± 2.8 P=0.001 
V̇O2peak (mL.kg-1.min-1) 47.3 ± 8.0 20.9 ± 3.4 P<0.001 
Peak power (W.kg-1) 3.7 ± 0.8 1.5 ± 0.3 P<0.001 
LTL (AU) 1.24 ± 0.85 0.56 ± 0.27 P<0.001 
MTL (AU) 1.06 ± 0.38 0.97 ± 0.25 P=0.45 
BMI: Body Mass Index; W: Watts; LTL: Leukocyte Telomere Length; MTL: Skeletal Muscle Telomere Length; AU: arbitrary units. 
Data is shown as Mean ± SD. 
 
 
Figure 1. Association between LTL (top) and MTL (bottom) 
with aerobic capacity score adjusted for age.  
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A limitation of this study was its cross-sectional 
nature, and while it would be optimal to conduct a 
longitudinal study in the same individuals, this was not 
feasible. We acknowledge that there is a relatively low 
sample size in our older-adults group (n=11). This 
relatively small sample size is due to the difficulty to 
recruit older adults for an invasive study with a muscle 
biopsy. Telomere length is highly variable between 
individuals and is impacted by multiple genetic, 
epigenetic and environmental factors [10, 11, 54, 55]. 
While we cannot fully account for all these factors, a 
strength of this study is that our cohort is very 
homogeneous with regards to confounding factors  
that can impact TL (i.e. all participants were non-
smokers, recreationally active men). Further, we used 
comprehensive and valid measures of aerobic capacity 
and created a robust aerobic score to best reflect  
the aerobic capacity of a person at the physiological 
level. 
 
CONCLUSIONS 
 
In apparently healthy individuals, age explains most of 
the variability of LTL and this appears to be 
independent of individual aerobic capacity. Individuals 
with longer LTL also have a longer MTL, suggesting 
that there might be a shared molecular mechanism 
regulating telomere length. Whether specific exercise 
interventions with either high or low intensity com-
ponents can alter telomere maintenance pathways and 
regulate telomere length would be interesting to explore 
in future studies. 
 
 
 
Figure 2. Association between LTL (Left) and MTL (Right) with age. 
 
 
Figure 3. Correlation between MTL and LTL. 
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MATERIALS AND METHODS 
 
Participants 
 
This was a cross-sectional study involving two cohorts 
of men: the Gene SMART (Skeletal Muscle Adaptive 
Response to Training) cohort of 82 men aged 18–45 
years, and the Wellderly cohort of 11 men aged 64–87 
years. Participants’ characteristics are presented in 
Table 1. All participants were asked to abstain from 
food, caffeine and alcohol for at least 8 hours prior to 
blood and muscle collection. 
 
The gene SMART, young cohort 
82 recreationally active (V̇O2peak: 47.3±8.0 mL.kg-1. 
min-1) men aged 18–45 years participated in the study 
following a written informed consent. Volunteers were 
excluded if they had a chronic disease, were taking 
medications, warfarin or vitamin K supplementation,  
or medications that affect metabolism, insulin 
secretion/sensitivity. Further, participants with known 
musculoskeletal or other conditions that prevent daily 
activity were excluded from the study. The full methods 
of the Gene SMART study are described elsewhere [56]. 
This study was approved by the Human Ethics Research 
Committee at Victoria University (HRE13-223). 
 
The wellderly, older cohort 
11 men aged 64–87 years were included in this study. 
The men were recruited as part of a larger study 
examining the effect of acute exercise in older-adults. 
This study has been approved by Melbourne Health 
(MH) Human Research Ethics Committee and is 
registered with the Australia New Zealand Clinical 
Trials Registry ACTRN12618001756213. Volunteers 
were excluded if they had any fractures in the previous 3 
months, or had undergone a new osteoporotic treatment 
within 3 months or had begun taking anti-resorptive 
medications within 3 months, have diagnosed diabetes 
mellitus or were taking hypoglycaemic medications, any 
haematological, myelodysplastic or myeloproliferative 
disorder, any bone malignancy, taking warfarin of 
vitamin K supplementation or restriction, a body mass 
index > 40 kg/m2, or engaged in resistance exercise 
regime more than 2 sessions per week. 
 
Skeletal muscle and blood collection 
 
In both cohorts, muscle biopsies were collected from 
the vastus lateralis muscle after an overnight fast by an 
experienced medical doctor. Following injection of a 
local anaesthetic (1% Lidocaine), incisions were made, 
and the biopsy needle inserted. Muscle samples were 
collected with manual suction applied [56]. Following 
collection, the samples (50–200 mg) were immediately 
blotted on filter paper to remove excess blood and 
placed immediately in liquid nitrogen before being 
stored at −80 °C until analysis. 
 
Venous blood samples were collected by venepuncture 
or cannulation just before the muscle biopsy. Five mL 
of venous blood were collected in EDTA blood 
collection tubes (Becton, Dickinson and Company, 
USA), inverted 6–10 times, centrifuged at 3500 rpm for 
10 min at 4°C. The plasma was collected and placed in 
Eppendorf tubes for other analysis. The residual blood 
sample (which includes the leukocytes) was frozen at -
20°C overnight before being stored at −80 °C until 
DNA extraction. 
 
Aerobic capacity 
 
Young cohort 
Aerobic capacity was assessed by a graded exercise test 
(GXT). Briefly, the test consisted of 4-minute exercise 
stages, separated by 30 second rest periods until 
voluntary exhaustion [56]. 
 
Older cohort 
Peak oxygen consumption (V̇O2Peak) was assessed on a 
cycle ergometer with the initial intensity beginning at 
10–30 Watts and increasing by 10–30W×min-1 
according to participant capacity. The test was 
terminated according to participants’ self-reported 
fatigue perception reaching a pre-determined level (Rate 
of Perceived Exertion=17) [57] or clinical signs or 
symptoms. Blood pressure was monitored at baseline, 
regular intervals (each stage) and post exercise using a 
manual sphygmomanometer, and heart rate was 
monitored via the 12-lead ECG. 
 
Telomere assays 
TL was measured in skeletal muscle and leukocytes 
collected at baseline (in a rested state). Skeletal muscle 
previously stored at –80°C was lysed with the RLT 
buffer Plus buffer (Qiagen) and beta-mercaptoethanol 
using the TissueLyser II (Qiagen, Australia). DNA was 
extracted using the AllPrep DNA/RNA Mini Kit 
following the manufacturer guidelines (Qiagen, 
Australia). DNA yield and purity were assessed using 
the spectrophotometer (NanoDrop One, Thermofisher) 
before being stored at –20°C prior to the telomere 
assays. Genomic DNA was extracted from buffy-coat 
leukocytes from BD Vacutainer EDTA tubes using the 
MagSep Blood gDNA kit (0030 451.00, Eppendorf, 
Hamburg, Germany) [56]. DNA yield and purity were 
assessed using the spectrophotometer (NanoDrop One, 
Thermofisher) before being stored at –20°C prior to the 
telomere assays. The DNA 260/280 and 260/230 OD 
values were acceptable in the young (1.86 ± 0.07 and 
1.35 ± 0.27, respectively) and older (1.93 ± 0.02 and 
1.77 ± 0.40, respectively) cohorts. 
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The telomere (T) to single copy gene (S) ratio (T/S ratio) 
was calculated to provide telomere length in arbitrary 
units. Ten microliter reactions comprised of SensiFAST 
Lo-ROX (20×), 300nM of forward and reverse primers 
(telomere) or 300nM of forward and 500nM of reverse 
primers (36B4), H2O and 12.5 ng of DNA template 
were run in triplicate with no-template negative controls 
on a single 384-well plate in a thermo-cycler (Quant 
Studio 12K Flex System, ThermoFisher Scientific, 
Australia) and repeated twice. The primer sets and 
thermo-cycling conditions are described elsewhere [30]. 
The T/S ratios were calculated and expressed relative to 
the individual with the median T/S ratio using the 2–
ΔΔCT method. In skeletal muscle the inter-coefficients 
of variation for triplicates for the telomere and 36B4 
gene were acceptable (mean ± SD: 1.43 ± 0.53 and 1.91 
± 0.57, respectively). In leukocytes inter-coefficients of 
variation for triplicates for the telomere and 36B4 gene 
were also acceptable (mean ± SD: 3.61 ± 0.99 and 2.49 
± 0.96, respectively). In skeletal muscle the intra-
coefficients of variation for triplicates for the telomere 
and 36B4 gene were acceptable (mean ± SD: 1.23 ± 0.71 
and 1.3 ± 0.74, respectively). In leukocytes the inter-
coefficients of variation for triplicates for the telomere 
and 36B4 gene were also acceptable (mean ± SD: 2.3 ± 
1.3 and 1.9 ± 1.2, respectively). 
 
Statistical analysis 
 
All data were analysed using R studio version 1.1.463. 
Mann-Whitney tests were used to compare charac-
teristics between the young and older cohorts. The 
distributions of LTL and MTL were verified for 
normality visually using histograms and were log-
transformed to meet normality assumptions. To examine 
the additive effect of fitness measures on telomere 
length, we calculated a fitness score by combining peak 
power and V̇O2peak into a single value. First, we 
calculated the z-score for each fitness measure, and then 
we averaged those z-scores across all fitness measures to 
calculate the final aerobic capacity score. Robust linear 
models, using the rlm function of the MASS package in 
R [58], were then performed with log-transformed 
telomere length as the dependent variable, and both age 
and fitness parameters (peak power, V̇O2peak, or 
aerobic capacity score) as the independent variables. A 
likelihood ratio test was used to compare the full model 
containing both age and fitness parameters (peak power, 
V̇O2peak, or aerobic capacity score), with a null model 
containing only age, as implemented in the lrtest 
function of the lmtest package in R [59]. Spearman 
correlations were used to test for an association between 
MTL and LTL. P values from the statistical analyses 
were adjusted for multiple testing using the false 
discovery rate (FDR) [60], and q-values<0.05 were 
deemed significant. 
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SUPPLEMENTARY MATERIALS 
 
 
Supplementary Table 1. Association between fitness parameters and MTL or LTL adjusted for age. 
 
Model adjusted for age  
VO2peak (mL.kg-1.min-1) Peak Power (W.kg-1) Aerobic Capacity Score (AU) 
MTL 
β= 0.07 β= 0.13 β= 0.08 
P= 0.59 P= 0.4 P= 0.5 
Q= 0.8 Q= 0.8 Q= 0.8 
LTL 
β= 0.034 β= 0.07 β= 0.06 
P= 0.5 P= 0.3 P= 0.3 
Q= 0.5 Q= 0.45 Q= 0.45 
AU: Arbitrary Units; LTL: Leukocyte Telomere Length; MTL: Skeletal Muscle Telomere Length. P-values were adjusted for 
multiple testing using the false discovery rate (FDR). Effect size corresponds to the regression coefficient in the linear models 
and is interpreted as the change in MTL or LTL (log-transformed) adjusted for age per unit change in fitness parameter. 
 
